株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

合成代用骨移植片:医療機器のパイプライン評価

Synthetic Bone Graft Substitutes - Medical Devices Pipeline Assessment, 2017

発行 GlobalData 商品コード 408134
出版日 ページ情報 英文 221 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.81円で換算しております。
Back to Top
合成代用骨移植片:医療機器のパイプライン評価 Synthetic Bone Graft Substitutes - Medical Devices Pipeline Assessment, 2017
出版日: 2017年10月01日 ページ情報: 英文 221 Pages
概要

当レポートでは、世界の合成代用骨移植片の関連市場における、主要なパイプライン製品 (医療機器) とその治験の進行状況について調査すると共に、製品特性の比較分析 (治験の進行段階別) や、主要企業のプロファイルおよび代表的製品、昨今の市場動静 (資本取引・事業提携など) といった情報を取りまとめてお届けいたします。

第1章 目次

第2章 イントロダクション

  • 合成代用骨移植片の概要

第3章 現在治験中の製品

  • パイプライン製品:治験段階別
  • パイプライン製品:領域別
  • パイプライン製品:規制経路別
  • パイプライン製品:推定認証時期別
  • 現在進行中の治験

第4章 合成代用骨移植片:各企業で現在治験中のパイプライン製品

  • 合成代用骨移植片の企業:治験段階別のパイプライン製品
  • 合成代用骨移植片:治験段階別のパイプライン製品

第5章 合成代用骨移植片の企業・製品の概要

  • Advanced Biologics, LLC
    • パイプライン製品および進行中の治験の概要
  • Aeon Astron Corporation
  • Agenta Biotechnologies, Inc.
  • Allergan, Inc.
  • Alphatec Holdings Inc
  • Anika Therapeutics Inc
  • Baxter International Inc
  • Berkeley Advanced Biomaterials, Inc.
  • Bio2 Technologies, Inc.
  • Bone Solutions, Inc.
  • BoneGrafix, Inc.
  • BoneSupport AB
  • Calcitec, Inc.
  • Citrics Biomedical, LLC
  • curasan AG
  • DSM Biomedical B.V.
  • Graftys SAS
  • Inion Oy
  • Innovia LLC
  • Integra LifeSciences Holdings Corp
  • King's College London
  • Maxigen Biotech Inc
  • Meta Biomed Co Ltd
  • N2 Biomedical
  • National Center of Innovation for Biomaterials in Orthopaedic Research
  • NovaBone Products LLC
  • NuVasive Inc
  • Orthogen LLC
  • PolyPid Ltd
  • Promimic AB
  • RepRegen Ltd. (Inactive)
  • Revivicor Inc
  • San Raffaele hospital
  • Scil Technology GmbH
  • SIRAKOSS Limited
  • Soft Tissue Regeneration Inc
  • Soteira Inc.
  • Trinity College Dublin
  • University of California San Diego
  • University of Edinburgh
  • University of Nottingham's School of Pharmacy
  • Wound Management Technologies Inc
  • Wright Medical Group NV

第6章 合成代用骨移植片市場:昨今の動向 (全86件)

第7章 付録

図表一覧

目次
Product Code: GDME0471EPD

GlobalData's Medical Devices sector report, "Synthetic Bone Graft Substitutes - Medical Devices Pipeline Assessment, 2017" provides an overview of Synthetic Bone Graft Substitutes currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Synthetic Bone Graft Substitutes pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Synthetic Bone Graft Substitutes under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Synthetic Bone Graft Substitutes and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Synthetic Bone Graft Substitutes under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 6
  • 1.2 List of Figures 9

2 Introduction 10

  • 2.1 Synthetic Bone Graft Substitutes Overview 10

3 Products under Development 11

  • 3.1 Synthetic Bone Graft Substitutes - Pipeline Products by Stage of Development 11
  • 3.2 Synthetic Bone Graft Substitutes - Pipeline Products by Territory 12
  • 3.3 Synthetic Bone Graft Substitutes - Pipeline Products by Regulatory Path 13
  • 3.4 Synthetic Bone Graft Substitutes - Pipeline Products by Estimated Approval Date 14
  • 3.5 Synthetic Bone Graft Substitutes - Ongoing Clinical Trials 15

4 Synthetic Bone Graft Substitutes - Pipeline Products under Development by Companies 16

  • 4.1 Synthetic Bone Graft Substitutes Companies - Pipeline Products by Stage of Development 16
  • 4.2 Synthetic Bone Graft Substitutes - Pipeline Products by Stage of Development 18

5 Synthetic Bone Graft Substitutes Companies and Product Overview 20

  • 5.1 Advanced Biologics LLC Company Overview 20
  • 5.2 Aeon Astron Corporation Company Overview 21
  • 5.3 Agenta Biotechnologies Inc Company Overview 22
  • 5.4 Allegra Orthopaedics Ltd Company Overview 23
  • 5.5 Alphatec Holdings Inc Company Overview 24
  • 5.6 Amend Surgical, Inc. Company Overview 25
  • 5.7 Anika Therapeutics Inc Company Overview 26
  • 5.8 Baxter International Inc Company Overview 27
  • 5.9 Berkeley Advanced Biomaterials Inc Company Overview 29
  • 5.10 Bio2 Technologies, Inc. Company Overview 31
  • 5.11 Bone Solutions Inc Company Overview 32
  • 5.12 BoneGrafix, Inc. Company Overview 35
  • 5.13 BoneSupport AB Company Overview 36
  • 5.14 Calcitec, Inc. Company Overview 39
  • 5.15 Citrics Biomedical, LLC (Inactive) Company Overview 40
  • 5.16 curasan AG Company Overview 41
  • 5.17 DSM Biomedical BV Company Overview 44
  • 5.18 Graftys SA Company Overview 45
  • 5.19 Inion Oy Company Overview 49
  • 5.20 Innovia LLC Company Overview 50
  • 5.21 King's College London Company Overview 51
  • 5.22 Kuros Biosciences AG Company Overview 52
  • 5.23 Maxigen Biotech Inc Company Overview 54
  • 5.24 Meta Biomed Co Ltd Company Overview 57
  • 5.25 N2 Biomedical Company Overview 58
  • 5.26 National Center of Innovation for Biomaterials in Orthopaedic Research Company Overview 59
  • 5.27 NovaBone Products LLC Company Overview 60
  • 5.28 NuVasive Inc Company Overview 61
  • 5.29 Orthocell Ltd Company Overview 64
  • 5.30 Orthogem Company Overview 65
  • 5.31 Orthogen LLC Company Overview 66
  • 5.32 PolyPid Ltd Company Overview 67
  • 5.33 Promimic AB Company Overview 70
  • 5.34 RepRegen Ltd. (Inactive) Company Overview 71
  • 5.35 Revivicor Inc Company Overview 73
  • 5.36 San Raffaele hospital Company Overview 74
  • 5.37 Scil Technology GmbH Company Overview 75
  • 5.38 SIRAKOSS Ltd Company Overview 76
  • 5.39 Sofregen Medical Inc Company Overview 78
  • 5.40 Soft Tissue Regeneration Inc Company Overview 80
  • 5.41 Soteira Inc Company Overview 81
  • 5.42 Trinity College Dublin Company Overview 82
  • 5.43 University of California San Diego Company Overview 83
  • 5.44 University of Edinburgh Company Overview 84
  • 5.45 University of Nottingham's School Of Pharmacy Company Overview 85
  • 5.46 Wound Management Technologies Inc Company Overview 86
  • 5.47 Wright Medical Group NV Company Overview 87

6 Synthetic Bone Graft Substitutes- Recent Developments 90

  • 6.1 Aug 29, 2017: Globus Medical Appoints David M. Demski as CEO 90
  • 6.2 Aug 29, 2017: NuVasive Announces World-Class Innovation Center At San Diego Headquarters 90
  • 6.3 Aug 28, 2017: Kuros receives clearance for MagnetOs Putty for commercialization in the United States and files the product for CE marking in Europe 91
  • 6.4 Aug 28, 2017: Anika Announces Appointment of Steven Chartier as Vice President of Regulatory and Clinical Affairs 92
  • 6.5 Aug 25, 2017: Sr-­HT-­Gahnite Bone Substitute Project Update 93
  • 6.6 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 93
  • 6.7 Aug 17, 2017: BONESUPPORT Holding: Interim Report January - June 2017 96
  • 6.8 Aug 15, 2017: NuVasive Appoints Rajesh J. Asarpota As Chief Financial Officer 97
  • 6.9 Aug 14, 2017: Governor McAuliffe Announces LifeNet Health to Invest $12.25 million, Create 321 New Jobs in City of Virginia Beach 97
  • 6.10 Aug 14, 2017: aap: Q2 sales and EBITDA in line with guidance; 14% sales growth in trauma in H1/2017aap: Q2 sales and EBITDA in line with guidance; 14% sales growth in trauma in H1/2017Berlin, 14 August 2017 98
  • 6.11 Aug 10, 2017: Alphatec Holdings Reports Second Quarter 2017 Financial Results 100
  • 6.12 Aug 09, 2017: Novadaq Receives Court Approval for Arrangement With Stryker 101
  • 6.13 Aug 08, 2017: RTI Surgical Announces 2017 Second Quarter Results 101
  • 6.14 Aug 02, 2017: Globus Medical Reports Second Quarter 2017 Results 103
  • 6.15 Aug 02, 2017: Wright Medical Group Reports 2017 Second Quarter Financial Results 104
  • 6.16 Aug 02, 2017: Stryker announces election of new Director, Mary K. Brainerd 106
  • 6.17 Jul 27, 2017: Hoya Reports First Quarter Financial Results 107
  • 6.18 Jul 27, 2017: Zimmer Biomet Reports Second Quarter 2017 Financial Results 107
  • 6.19 Jul 27, 2017: Stryker reports second quarter 2017 results 108
  • 6.20 Jul 27, 2017: Anika Announces Appointment of Joseph Darling as President 109
  • 6.21 Jul 27, 2017: NuVasive Announces New Organizational Structure To Drive Growth And Profitability Goals 110
  • 6.22 Jul 27, 2017: NuVasive Reports Second Quarter 2017 Financial Results 111
  • 6.23 Jul 26, 2017: Baxter Reports Second-Quarter 2017 Results and Provides Updated Financial Outlook for 2017 and 2020 112
  • 6.24 Jul 26, 2017: Integra LifeSciences Reports Second Quarter 2017 Financial Results 114
  • 6.25 Jul 26, 2017: Anika Reports Strong Second Quarter 2017 Financial Results 116
  • 6.26 Jul 20, 2017: Wound Management Technologies Announces Q2 2017 Sales Up 15% over Q2 2016 and All Amortized Debt Retired in the Second Quarter 117
  • 6.27 Jul 18, 2017: Spineway: Confirmed growth Revenue for the first half of 2017: €6M (+146%) 117
  • 6.28 Jul 17, 2017: Baxter Appoints Cathy R. Smith to its Board 118
  • 6.29 Jul 11, 2017: Zimmer Biomet Announces Leadership Transition 118
  • 6.30 Jul 11, 2017: Zimmer Biomet Reports Certain Preliminary Second Quarter 2017 Results 119
  • 6.31 Jul 11, 2017: Medicrea Reports First Half 2017 Sales 119
  • 6.32 Jun 15, 2017: aap: Supervisory Board extends both Management Board members' contracts prematurely until the end of 2020 120
  • 6.33 Jun 14, 2017: Spineway Records a New $1M Order in the USA 121
  • 6.34 Jun 13, 2017: Zimmer Biomet Holdings Announces Resolution of FDA Warning Letter Related to Its Zhejiang, China Manufacturing Facility 121
  • 6.35 Jun 06, 2017: Kuros Biosciences submits MagnetOs Putty for US FDA Clearance 121
  • 6.36 Jun 01, 2017: NuVasive Appoints Skip Kiil As Executive Vice President, International 122
  • 6.37 May 31, 2017: Depuy Synthes and Ethicon to Showcase Intra Operative Solutions Aiming to Mitigate Surgical Site Infection During Efort Congress 122
  • 6.38 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 124
  • 6.39 May 24, 2017: NovaBone Announces Irrigation Resistant Products with Carriers that have Synergistic Effect in Bone Formation 127
  • 6.40 May 24, 2017: NovaBone Provides Update on NovaBone IRM MacroPO 127
  • 6.41 May 22, 2017: BONESUPPORT Announces First Patient Enrolled in FORTIFY Trial With CERAMENT G, a Novel Injectable, Antibiotic-eluting Bone Graft Substitute 128
  • 6.42 May 22, 2017: NuVasive Announces Educational Initiatives In Support Of Spine's Fastest Growing Spinal Deformity Portfolio 129
  • 6.43 May 17, 2017: Wound Management Issues 2017 10Q and Hires New Strategic Marketing Director 130
  • 6.44 May 11, 2017: Hoya Reports Fourth Quarter and Full-Year Financial Results 130
  • 6.45 May 11, 2017: Alphatec Reports First Quarter 2017 Financial Results 131
  • 6.46 May 03, 2017: Globus Medical Reports First Quarter 2017 Results 132
  • 6.47 May 03, 2017: Wright Medical Group Reports 2017 First Quarter Financial Results 133
  • 6.48 May 03, 2017: Anika Reports First Quarter 2017 Financial Results 135
  • 6.49 Apr 28, 2017: Lennart Johansson to Join BONESUPPORT Board of Directors 136
  • 6.50 Apr 27, 2017: Zimmer Biomet Reports First Quarter 2017 Financial Results 136
  • 6.51 Apr 27, 2017: RTI Surgical Announces 2017 First Quarter Results 137
  • 6.52 Apr 27, 2017: Q1 2017 Sales Up 32% Over Q1 2016, for Wound Management Technologies 139
  • 6.53 Apr 26, 2017: Integra LifeSciences Reports First Quarter 2017 Financial Results 139
  • 6.54 Apr 26, 2017: Baxter Reports First-Quarter 2017 Results and Increases Financial Outlook for Full-Year 2017 140
  • 6.55 Apr 26, 2017: Spineway: 2016 Annual results 142
  • 6.56 Apr 25, 2017: Stryker reports first quarter 2017 results 143
  • 6.57 Apr 25, 2017: NuVasive Announces First Quarter 2017 Financial Results 144
  • 6.58 Apr 13, 2017: Medicrea Releases First Quarter Sales For 2017 145
  • 6.59 Apr 11, 2017: BONESUPPORT Appoints Michael Diefenbeck as Chief Medical Officer 146
  • 6.60 Mar 31, 2017: aap: Annual financial statements for 2016: aap with fundamental progress in strategy implementation - Transformation to a pure player in trauma completed 146
  • 6.61 Mar 30, 2017: Medicrea Announces 2016 Annual Results 148
  • 6.62 Mar 24, 2017: Alphatec Completes its Senior Leadership Team with Appointment of Brian Snider, Executive Vice President, Strategic Marketing and Product Development 149
  • 6.63 Mar 15, 2017: Alphatec Holdings Announces Fourth Quarter and Full Year 2016 Financial Results 150
  • 6.64 Mar 09, 2017: PolyPid Announces Positive Interim Data from Company's Confirmatory Clinical Trial for BonyPid-1000 Antibiotic Eluting Bone Substitute 152
  • 6.65 Mar 08, 2017: Wound Management announces appointment of John Siedhoff as Chairman 153
  • 6.66 Feb 28, 2017: Synergy Biomedical Receives CE Mark for BIOSPHERE PUTTY 153
  • 6.67 Feb 27, 2017: Globus Medical Reports Full Year and Fourth Quarter 2016 Results 154
  • 6.68 Feb 23, 2017: RTI Surgical Announces 2016 Fourth Quarter, Full Year Results; Initiates Actions to Improve Execution and Return to Profitable Growth 155
  • 6.69 Feb 23, 2017: Integra LifeSciences Reports Fourth Quarter and Full-Year 2016 Financial Results and Updates 2017 Full-Year Guidance 157
  • 6.70 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 158
  • 6.71 Feb 21, 2017: Wright Medical Group Reports 2016 Fourth Quarter and Full-Year Financial Results and Provides 2017 Guidance 161
  • 6.72 Feb 15, 2017: Anika Reports Fourth Quarter and Full Year 2016 Financial Results 163
  • 6.73 Feb 15, 2017: Anika Therapeutics Reports 33% Revenue Growth in Third Quarter 2011 164
  • 6.74 Feb 14, 2017: Alphatec Spine Announces Appointment of David H. Mowry to its Board of Directors 165
  • 6.75 Feb 14, 2017: Wound Management Technologies Announces Record Quarterly and Annual Sales Ending December 31, 2016 - Up 147% over Q4 2015, and 63% over 2015 166
  • 6.76 Feb 10, 2017: Allegra Orthopaedics Provides Update on Sr-HT-Gahnite Bone Substitute Project 166
  • 6.77 Feb 09, 2017: NuVasive Reports Fourth Quarter And Full Year 2016 Financial Results 167
  • 6.78 Feb 08, 2017: Baxter Appoints Dr. Stephen Oesterle to Its Board 168
  • 6.79 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 169
  • 6.80 Feb 01, 2017: Baxter Reports 2016 Fourth-Quarter and Full-Year Results 169
  • 6.81 Jan 31, 2017: Zimmer Biomet Reports Fourth Quarter and Full-Year 2016 Financial Results 172
  • 6.82 Jan 31, 2017: Hoya Announces Third Quarter Financial Results 173
  • 6.83 Jan 26, 2017: RTI Surgical Names Camille Farhat Chief Executive Officer 173
  • 6.84 Jan 26, 2017: Calmare Theraeutics Board of Directors Changes 174
  • 6.85 Jan 24, 2017: Stryker reports 2016 results and 2017 outlook 174
  • 6.86 Jan 18, 2017: Karolinska Development portfolio company Promimic appoints Magnus Larsson as new CEO and launches US sales operation 176
  • 6.87 Jan 17, 2017: Zimmer Biomet Announces Americas Leadership Transition 176
  • 6.88 Jan 17, 2017: RTI Surgical Extends Deadline for Nominating Directors to the Board 177
  • 6.89 Jan 16, 2017: SurgaColl Technologies: Board Announcement - Appointment of CEO 177
  • 6.90 Jan 12, 2017: Zimmer Biomet Announces Resolution with DOJ and SEC Regarding Previously Disclosed Legacy Biomet FCPA Matters 177
  • 6.91 Jan 12, 2017: Medicrea Releases Annual Sales for 2016 178
  • 6.92 Jan 10, 2017: Stryker provides 2016 preliminary net sales results 178
  • 6.93 Jan 10, 2017: Zimmer Biomet Announces Fourth Quarter and Full-Year 2016 Preliminary Sales Results 179
  • 6.94 Jan 10, 2017: Globus Medical Reports Preliminary Fourth Quarter and Full Year Sales Results 180
  • 6.95 Jan 09, 2017: NuVasive Announces Select Preliminary Unaudited Full Year 2016 Financial Results and 2017 Outlook 181
  • 6.96 Jan 06, 2017: BONESUPPORT CEO Richard Davies to present at Medtech Showcase 2017 181
  • 6.97 Jan 03, 2017: Calmare Therapeutics Reports Third Quarter 2016 Results 182
  • 6.98 Dec 21, 2016: Bjorn Westberg to Join BONESUPPORT as Chief Financial Officer 183
  • 6.99 Dec 16, 2016: BONESUPPORT Confirms Election of Dr. Hakan Bjorklund as Chairman of the Board 183
  • 6.100 Dec 14, 2016: RTI Surgical Names Robert P. Jordheim Interim CEO 184
  • 6.101 Dec 14, 2016: Zimmer Biomet Update on Product Supply Matters and Responsive Statement on Recently Completed FDA Inspection 184
  • 6.102 Dec 12, 2016: Alphatec Holdings appoints new CEO 185
  • 6.103 Dec 12, 2016: Alphatec Holdings Announces Board and Executive Leadership Changes 186
  • 6.104 Dec 08, 2016: Wound Management Technologies Welcomes J. Michael Carmena as its New CFO 188
  • 6.105 Dec 07, 2016: curasan receives market clearance for orthopedic product in the strategically important US market 188
  • 6.106 Dec 05, 2016: Integra LifeSciences announces management changes 189
  • 6.107 Dec 05, 2016: Integra LifeSciences Announces Key Executive Appointments 190
  • 6.108 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 190
  • 6.109 Nov 22, 2016: Collagen Matrix Names Oystein Valberg as Chief Financial Officer 193
  • 6.110 Nov 17, 2016: New UK Business Manager Appointed At JRI Orthopaedics 194
  • 6.111 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 194
  • 6.112 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 195
  • 6.113 Nov 10, 2016: Curasan Continues Dynamic Growth in the Third Quarter 195
  • 6.114 Nov 09, 2016: Alphatec Holdings Announces Third Quarter 2016 Revenue and Financial Results 196
  • 6.115 Nov 08, 2016: Globus Medical Reports Third Quarter 2016 Results 199
  • 6.116 Nov 07, 2016: BONESUPPORT Announces Key Corporate Appointment To Drive Growth In North America 200
  • 6.117 Nov 03, 2016: DSM Q3 2016 Results 200
  • 6.118 Nov 02, 2016: Wright Medical Group Reports 2016 Third Quarter Financial Results and Updates 2016 Guidance 202
  • 6.119 Nov 01, 2016: Wound Management Technologies Reports Preliminary Financial Results For Q3 2016 Sales Up 56% over Q3 2015, and 2016 YTD Sales Up 41% over 2015 YTD Sales 204
  • 6.120 Oct 31, 2016: Allegra Orthopaedics Provides Update on Sr-HT-Gahnite Bone Substitute 205
  • 6.121 Oct 31, 2016: Zimmer Biomet Reports Third Quarter 2016 Financial Results 205
  • 6.122 Oct 28, 2016: Hoya Reports Second Quarter Results 206
  • 6.123 Oct 27, 2016: Karolinska Development Portfolio Company Promimic Appoints New Chairman and Directors to its Board 207
  • 6.124 Oct 27, 2016: Stryker reports third quarter 2016 results 207
  • 6.125 Oct 27, 2016: Integra LifeSciences Reports Third Quarter 2016 Financial Results 208
  • 6.126 Oct 26, 2016: Anika Reports Third Quarter 2016 Financial Results 209
  • 6.127 Oct 25, 2016: RTI Surgical Announces 2016 Third Quarter Results 210
  • 6.128 Oct 25, 2016: Baxter Reports Third Quarter 2016 Results and Increases Financial Outlook For Full-Year 2016 211
  • 6.129 Oct 25, 2016: NuVasive Reports Third Quarter 2016 Financial Results 213
  • 6.130 Oct 06, 2016: Medicrea Announces 2016 Third-Quarter Sales 214
  • 6.131 Oct 05, 2016: Alphatec Holdings Announces Company Updates 215
  • 6.132 Sep 27, 2016: Orange County Business Council Study Showcases Economic Impact of Allergan on California Economy 216

7 Appendix 217

  • 7.1 Methodology 217
  • 7.2 About GlobalData 220
  • 7.3 Contact Us 220
  • 7.4 Disclaimer 220

List of Tables

1.1 List of Tables

  • Table 1: Synthetic Bone Graft Substitutes - Pipeline Products by Stage of Development 12
  • Table 2: Synthetic Bone Graft Substitutes - Pipeline Products by Territory 13
  • Table 3: Synthetic Bone Graft Substitutes - Pipeline Products by Regulatory Path 14
  • Table 4: Synthetic Bone Graft Substitutes - Pipeline Products by Estimated Approval Date 15
  • Table 5: Synthetic Bone Graft Substitutes - Ongoing Clinical Trials 16
  • Table 6: Synthetic Bone Graft Substitutes Companies - Pipeline Products by Stage of Development 17
  • Table 7: Synthetic Bone Graft Substitutes - Pipeline Products by Stage of Development 19
  • Table 8: Advanced Biologics LLC Pipeline Products & Ongoing Clinical Trials Overview 21
  • Table 9: OsteoMEM Synthetic Bone Graft Substitute - Product Status 21
  • Table 10: OsteoMEM Synthetic Bone Graft Substitute - Product Description 21
  • Table 11: Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview 22
  • Table 12: BioBone Filler - Product Status 22
  • Table 13: BioBone Filler - Product Description 22
  • Table 14: Agenta Biotechnologies Inc Pipeline Products & Ongoing Clinical Trials Overview 23
  • Table 15: B-247 Cranial Bone Graft Implant - Product Status 23
  • Table 16: B-247 Cranial Bone Graft Implant - Product Description 23
  • Table 17: Allegra Orthopaedics Ltd Pipeline Products & Ongoing Clinical Trials Overview 24
  • Table 18: Sr-HT-Gahnite Bone Substitute - Product Status 24
  • Table 19: Sr-HT-Gahnite Bone Substitute - Product Description 24
  • Table 20: Alphatec Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 25
  • Table 21: Bonex - Product Status 25
  • Table 22: Bonex - Product Description 25
  • Table 23: Amend Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 24: Biomimetic Bone - Product Status 26
  • Table 25: Biomimetic Bone - Product Description 26
  • Table 26: Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 27
  • Table 27: Hyalobone - Product Status 27
  • Table 28: Hyalobone - Product Description 27
  • Table 29: Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview 28
  • Table 30: Synthetic Bone Graft - Orthopaedic - Product Status 28
  • Table 31: Synthetic Bone Graft - Orthopaedic - Product Description 28
  • Table 32: Synthetic Bone Graft - Spinal - Product Status 29
  • Table 33: Synthetic Bone Graft - Spinal - Product Description 29
  • Table 34: Berkeley Advanced Biomaterials Inc Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 35: CPA Ceramics - Product Status 30
  • Table 36: CPA Ceramics - Product Description 30
  • Table 37: HAP Ceramics - Product Status 31
  • Table 38: HAP Ceramics - Product Description 31
  • Table 39: Bio2 Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 40: Hammertoe Intramedullary Fusion Device - Product Status 32
  • Table 41: Hammertoe Intramedullary Fusion Device - Product Description 32
  • Table 42: Bone Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 43: Osteocrete - Bone Anchor - Product Status 33
  • Table 44: Osteocrete - Bone Anchor - Product Description 33
  • Table 45: OsteoCrete - Cranial - Product Status 34
  • Table 46: OsteoCrete - Cranial - Product Description 34
  • Table 47: OsteoCrete - Maxillofacial - Product Status 34
  • Table 48: OsteoCrete - Maxillofacial - Product Description 35
  • Table 49: OsteoCrete - Non Load Bearing Spine - Product Status 35
  • Table 50: OsteoCrete - Non Load Bearing Spine - Product Description 35
  • Table 51: BoneGrafix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
  • Table 52: Solid Bone Block - Product Status 36
  • Table 53: Solid Bone Block - Product Description 36
  • Table 54: BoneSupport AB Pipeline Products & Ongoing Clinical Trials Overview 37
  • Table 55: Cerament|G - Product Status 37
  • Table 56: Cerament|G - Product Description 37
  • Table 57: BoneSupport AB - Ongoing Clinical Trials Overview 38
  • Table 58: Cerament|G - A Prospective, Randomized Multicenter Controlled Trial of CERAMENT|G as Part of Surgical Repair of Open Diaphyseal Tibial Fractures 39
  • Table 59: Cerament|G - CERAMENT lBONE VOID FILLER and Gentamicin Eluting CERAMENT lG for Prophylactic Use in Bone Tumor Patients 39
  • Table 60: Cerament|G - CERAMENT/G - Bone Healing and Re-infection Prophylaxis 39
  • Table 61: Calcitec, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
  • Table 62: Corticell - Product Status 40
  • Table 63: Corticell - Product Description 40
  • Table 64: Citrics Biomedical, LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 65: CitrOSponge - Product Status 41
  • Table 66: CitrOSponge - Product Description 41
  • Table 67: curasan AG Pipeline Products & Ongoing Clinical Trials Overview 42
  • Table 68: Cerasorb Classic Ortho - Product Status 42
  • Table 69: Cerasorb Classic Ortho - Product Description 42
  • Table 70: Cerasorb M Ortho - Product Status 43
  • Table 71: Cerasorb M Ortho - Product Description 43
  • Table 72: Cerasorb Ortho Foam - Product Status 43
  • Table 73: Cerasorb Ortho Foam - Product Description 44
  • Table 74: Cerasorb Paste - Product Status 44
  • Table 75: Cerasorb Paste - Product Description 44
  • Table 76: DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 77: Structural Synthetic Bone Graft - Product Status 45
  • Table 78: Structural Synthetic Bone Graft - Product Description 45
  • Table 79: Graftys SA Pipeline Products & Ongoing Clinical Trials Overview 46
  • Table 80: GRFT-M04 - Product Status 46
  • Table 81: GRFT-M04 - Product Description 47
  • Table 82: GRFT-R02 - Product Status 47
  • Table 83: GRFT-R02 - Product Description 47
  • Table 84: Injectable Resorbable Material - Product Status 48
  • Table 85: Injectable Resorbable Material - Product Description 48
  • Table 86: Intelligent Bone Substitute - Infection - Product Status 48
  • Table 87: Intelligent Bone Substitute - Infection - Product Description 49
  • Table 88: Intelligent Bone Substitute - Post-Operative Intraosseous Pain - Product Status 49
  • Table 89: Intelligent Bone Substitute - Post-Operative Intraosseous Pain - Product Description 49
  • Table 90: Inion Oy Pipeline Products & Ongoing Clinical Trials Overview 50
  • Table 91: Biodegradable Cervical Interbody Fusion Block - Product Status 50
  • Table 92: Biodegradable Cervical Interbody Fusion Block - Product Description 50
  • Table 93: Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 51
  • Table 94: Vertebral Disc Filler - Product Status 51
  • Table 95: Vertebral Disc Filler - Product Description 51
  • Table 96: King's College London Pipeline Products & Ongoing Clinical Trials Overview 52
  • Table 97: Bone Graft Substitute - Product Status 52
  • Table 98: Bone Graft Substitute - Product Description 52
  • Table 99: Kuros Biosciences AG Pipeline Products & Ongoing Clinical Trials Overview 53
  • Table 100: MagnetOs Putty - Orthopedic And Dental - Product Status 53
  • Table 101: MagnetOs Putty - Orthopedic And Dental - Product Description 53
  • Table 102: MagnetOs Putty - Spinal Fusion - Product Status 54
  • Table 103: MagnetOs Putty - Spinal Fusion - Product Description 54
  • Table 104: Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 55
  • Table 105: Formasetin Injectable Bone Filler - Product Status 55
  • Table 106: Formasetin Injectable Bone Filler - Product Description 55
  • Table 107: MaxiCure - Product Status 56
  • Table 108: MaxiCure - Product Description 56
  • Table 109: MaxiSetin - Product Status 56
  • Table 110: MaxiSetin - Product Description 57
  • Table 111: Meta Biomed Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 58
  • Table 112: Bone Filler - Product Status 58
  • Table 113: Bone Filler - Product Description 58
  • Table 114: N2 Biomedical Pipeline Products & Ongoing Clinical Trials Overview 59
  • Table 115: Antimicrobial Biodegradable Bone Graft - Product Status 59
  • Table 116: Antimicrobial Biodegradable Bone Graft - Product Description 59
  • Table 117: National Center of Innovation for Biomaterials in Orthopaedic Research Pipeline Products & Ongoing Clinical Trials Overview 60
  • Table 118: Composite Bone Graft Substitute - Product Status 60
  • Table 119: Composite Bone Graft Substitute - Product Description 60
  • Table 120: NovaBone Products LLC Pipeline Products & Ongoing Clinical Trials Overview 61
  • Table 121: Bioengineered Resorbable Bone Graft - Orthopedic - Product Status 61
  • Table 122: Bioengineered Resorbable Bone Graft - Orthopedic - Product Description 61
  • Table 123: NuVasive Inc Pipeline Products & Ongoing Clinical Trials Overview 62
  • Table 124: AttraX Putty - Product Status 62
  • Table 125: AttraX Putty - Product Description 62
  • Table 126: NuVasive Inc - Ongoing Clinical Trials Overview 63
  • Table 127: AttraX Putty - A Randomized Controlled Trial of AttraX Putty vs. Autograft in Instrumented Posterolateral Spinal Fusion 64
  • Table 128: Orthocell Ltd Pipeline Products & Ongoing Clinical Trials Overview 65
  • Table 129: CelGro Collagen Scaffold - Bone Void Filling - Product Status 65
  • Table 130: CelGro Collagen Scaffold - Bone Void Filling - Product Description 65
  • Table 131: Orthogem Pipeline Products & Ongoing Clinical Trials Overview 66
  • Table 132: TriPore Putty - Product Status 66
  • Table 133: TriPore Putty - Product Description 66
  • Table 134: Orthogen LLC Pipeline Products & Ongoing Clinical Trials Overview 67
  • Table 135: DentoGen-CR - Product Status 67
  • Table 136: DentoGen-CR - Product Description 67
  • Table 137: PolyPid Ltd Pipeline Products & Ongoing Clinical Trials Overview 68
  • Table 138: BonyPid-1000 - Product Status 68
  • Table 139: BonyPid-1000 - Product Description 68
  • Table 140: PolyPid Ltd - Ongoing Clinical Trials Overview 69
  • Table 141: BonyPid-1000 - Safety and Performance of BonyPid-1000 in the Treatment of Gustilo IIIA and IIIB Tibial Open Fractures 70
  • Table 142: Promimic AB Pipeline Products & Ongoing Clinical Trials Overview 71
  • Table 143: HAnano Bone - Product Status 71
  • Table 144: HAnano Bone - Product Description 71
  • Table 145: RepRegen Ltd. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 72
  • Table 146: Bone Graft Substitute - Load Bearing - Product Status 72
  • Table 147: Bone Graft Substitute - Load Bearing - Product Description 72
  • Table 148: StronBone-P - Product Status 73
  • Table 149: StronBone-P - Product Description 73
  • Table 150: Revivicor Inc Pipeline Products & Ongoing Clinical Trials Overview 74
  • Table 151: Tendon - ACL Repair - Product Status 74
  • Table 152: Tendon - ACL Repair - Product Description 74
  • Table 153: San Raffaele hospital Pipeline Products & Ongoing Clinical Trials Overview 75
  • Table 154: Tissue Repair Composite Scaffold - Product Status 75
  • Table 155: Tissue Repair Composite Scaffold - Product Description 75
  • Table 156: Scil Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview 76
  • Table 157: ST01 Bone Graft Substitute Material - Product Status 76
  • Table 158: ST01 Bone Graft Substitute Material - Product Description 76
  • Table 159: SIRAKOSS Ltd Pipeline Products & Ongoing Clinical Trials Overview 77
  • Table 160: MaxSi Graft Granules - Product Status 77
  • Table 161: MaxSi Graft Granules - Product Description 77
  • Table 162: MaxSi Graft Putty - Product Status 78
  • Table 163: MaxSi Graft Putty - Product Description 78
  • Table 164: Sofregen Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 79
  • Table 165: SeriACL Scaffold - Product Status 79
  • Table 166: SeriACL Scaffold - Product Description 79
  • Table 167: SeriCuff Scaffold - Product Status 80
  • Table 168: SeriCuff Scaffold - Product Description 80
  • Table 169: Soft Tissue Regeneration Inc Pipeline Products & Ongoing Clinical Trials Overview 81
  • Table 170: L-C Ligament - Product Status 81
  • Table 171: L-C Ligament - Product Description 81
  • Table 172: Soteira Inc Pipeline Products & Ongoing Clinical Trials Overview 82
  • Table 173: Nanotechnology Bone Biomaterial - Spinal Repair - Product Status 82
  • Table 174: Nanotechnology Bone Biomaterial - Spinal Repair - Product Description 82
  • Table 175: Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 83
  • Table 176: Drug Eluting Porous Scaffold - Product Status 83
  • Table 177: Drug Eluting Porous Scaffold - Product Description 83
  • Table 178: University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 84
  • Table 179: Synthetic Bone Graft - Product Status 84
  • Table 180: Synthetic Bone Graft - Product Description 84
  • Table 181: University of Edinburgh Pipeline Products & Ongoing Clinical Trials Overview 85
  • Table 182: Shapeable Foam - Bone Repair - Product Status 85
  • Table 183: Shapeable Foam - Bone Repair - Product Description 85
  • Table 184: University of Nottingham's School Of Pharmacy Pipeline Products & Ongoing Clinical Trials Overview 86
  • Table 185: Injectable Bone - Product Status 86
  • Table 186: Injectable Bone - Product Description 86
  • Table 187: Wound Management Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 87
  • Table 188: Bone Void Filler - Product Status 87
  • Table 189: Bone Void Filler - Product Description 87
  • Table 190: Wright Medical Group NV Pipeline Products & Ongoing Clinical Trials Overview 88
  • Table 191: Augment Chronic Tendinopathy - Product Status 88
  • Table 192: Augment Chronic Tendinopathy - Product Description 89
  • Table 193: Augment Injectable Bone Graft - Product Status 89
  • Table 194: Augment Injectable Bone Graft - Product Description 89
  • Table 195: Augment Rotator Cuff Graft - Product Status 90
  • Table 196: Augment Rotator Cuff Graft - Product Description 90
  • Table 197: Glossary 220

List of Figures

1.2 List of Figures

  • Figure 1: Synthetic Bone Graft Substitutes - Pipeline Products by Stage of Development 12
  • Figure 2: Synthetic Bone Graft Substitutes - Pipeline Products by Territory 13
  • Figure 3: Synthetic Bone Graft Substitutes - Pipeline Products by Regulatory Path 14
  • Figure 4: Synthetic Bone Graft Substitutes - Pipeline Products by Estimated Approval Date 15
  • Figure 5: Synthetic Bone Graft Substitutes - Ongoing Clinical Trials 16
Back to Top